Company
cansinotech
To provide innovative, high-quality and affordable vaccines
Also known as CanSinoBIO
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
CanSinoBIO is an industry-leading biopharmaceutical company, dedicated to providing global solutions for the prevention and treatment of infectious diseases, through research & development, manufacturing and commercialization of vaccine products for human use.
Funding snapshot
- Latest round
- Grant2024-10-09
Funding rounds
- Grant
- 2024-10-09
Products
- Other
- Convidecia
- Other
- Convidecia Air
- Other
- iPneucia
- Other
- Menhycia
- Other
- Menphecia
- Other
- Tetcia
- Other
- Tripecia
Loading relationship preview